By univariate analysis, higher pathologic tumor (pT) stage, presence of lymph node metastasis, higher pTNM stage, chemotherapy regimen with both AC and taxane, lower level of TILs, and lower expression of p-eIF2a were negative prognostic factors for both disease-free and overall survival. This evidence concerns the gene EIF2A and metastatic malignant neoplasm in the lymph nodes.